Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 1/2 1

Status

Completed 15Recruiting 6Unknown 5Terminated 5Withdrawn 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Conditions

Neoplasms 87Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 73Recurrence 64Colorectal Neoplasms 63Pancreatic Neoplasms 60Melanoma 58Advanced Solid Tumor 57Carcinoma, Hepatocellular 56Multiple Myeloma 55Lymphoma 53Leukemia, Myeloid, Acute 53Advanced Solid Tumors 53Neoplasm Metastasis 50Stomach Neoplasms 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Lymphoma, B-Cell 40Solid Tumor 39Ovarian Neoplasms 38Lymphoma, Non-Hodgkin 38Lung Neoplasms 36Glioblastoma 35Prostatic Neoplasms 34Leukemia 28Head and Neck Neoplasms 27Leukemia, Lymphocytic, Chronic, B-Cell 26Uterine Cervical Neoplasms 25Burkitt Lymphoma 24Esophageal Neoplasms 23Urinary Bladder Neoplasms 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Advanced Malignancies × Clear all
NCT04671875 2024-03-13

A Clinical Study of MIL93 in Solid Tumors.

Beijing Mabworks Biotech Co., Ltd.

Phase 1 Unknown
228 enrolled

Advanced Malignancies

NCT04916119 2022-09-16

Study of IBI323 in Patients With Advanced Malignancies

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Unknown
322 enrolled

Advanced Malignancies

NCT04085185 2022-09-14

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Unknown
268 enrolled

Advanced Malignancies

NCT05024305 2022-03-09

Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.

Shandong TheraWisdom Biopharma Co., Ltd.

Phase 1 Unknown
81 enrolled

Advanced Malignancies

NCT04340427 2020-07-01

A Study of TQB3455 Tablets in Subjects With Advanced Malignancies

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
50 enrolled

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡